Delivery Order SPE2DE24D0021-SPE2D625F0DZ8
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,470.00 by the Defense Medical Supply Chain on August 19, 2025, for the supply of BinaxNOW COVID-19 antigen over-the-counter test kits (12 tests per box, 2 boxes per case). This fixed-price contract with economic price adjustment provisions represents a child contract under a larger vehicle and carries no set-aside designation. The order is scheduled for completion by August 26, 2025, with performance directed to...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,470.00 for BinaxNOW COVID-19 antigen over-the-counter test kits (12 tests per box, 2 boxes per case) on July 14, 2025. This fixed-price contract with economic price adjustment is a child order under a larger vehicle and requires completion by July 21, 2025. The order was placed through the Medical Supply Chain, a defense-focused federal agency, with performance occurring at Fisher Scientific's Pittsburgh, Pennsylvania...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,205.00 for BinaxNow COVID-19 antigen OTC test kits (12 tests per 2-test case) by the Defense Medical Supply Chain federal agency. The contract, awarded on September 9, 2025, with an ultimate completion date of September 16, 2025, utilizes a fixed price with economic price adjustment pricing structure. The place of performance is Pittsburgh, Pennsylvania. This delivery order represents a child contract, indicating...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $5,822.94 on April 24, 2025, for the procurement of BinaxNOW COVID-19 antigen testing kits. The contract, which represents no set-aside designation, will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of May 1, 2025. This delivery order is structured with economic price adjustment provisions and is funded through the Medical Supply Chain, a defense-oriented federal agency. Fisher...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $3,087.00 on September 11, 2025, for the supply of BinaxNow COVID-19 antigen over-the-counter test kits (12 tests per box, 2 boxes per case). This fixed-price contract with economic price adjustment carries a completion deadline of September 18, 2025, and will be performed in Pittsburgh, Pennsylvania. The award was issued by the Medical Supply Chain, a defense-focused federal agency, with no set-aside designation applied. As...
- Fisher Scientific Company L.L.C. was awarded a delivery order on July 11, 2025, for the procurement of BINAXNOW COVID-19 Antigen Over-the-Counter test kits (12 tests per box, case quantity) with a ceiling value of $1,176.00. The contract is a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of July 18, 2025. This award is a child contract under a larger vehicle and was issued without a set-aside designation, indicating open competition....
- Fisher Scientific Company L.L.C. was awarded a delivery order on August 4, 2025, for BinaxNow COVID-19 antigen over-the-counter rapid test kits (12 tests per 2-count case) valued at $1,311.20. This fixed-price delivery order with economic price adjustment was issued by the Medical Supply Chain division within the Department of Defense and is set to be completed by August 11, 2025. The contract represents a child award under a larger vehicle and specifies performance in Pittsburgh,...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,099.56 for BinaxNow COVID-19 antigen over-the-counter rapid tests (12 tests per box, 2 boxes per case) on July 29, 2025. This fixed-price contract with economic price adjustment capability will be performed in Pittsburgh, Pennsylvania and is scheduled for completion by August 5, 2025. The award was made without a set-aside designation, indicating open competition. The funding agency is the Medical Supply Chain, a...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,205.00 on June 2, 2025, for the procurement of BinaxNOW COVID-19 antigen over-the-counter test kits (12 tests per box, 2 boxes per case). This fixed-price delivery order with economic price adjustment is scheduled for completion by June 9, 2025, with performance taking place in Pittsburgh, Pennsylvania. The contract was awarded without a set-aside designation, reflecting open competition procurement. The funding agency is...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,897.80 on August 11, 2025, for the provision of BinaxNOW COVID antigen testing kits to support the Medical Supply Chain, a defense-oriented federal agency. This fixed-price delivery order with economic price adjustment capability represents a child contract under a larger vehicle and will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 18, 2025. No set-aside designation was applied...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F0DZ8Delivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,470.00 by the Medical Supply Chain, a defense-affiliated federal agency, on June 2, 2025, for the supply of BinaxNOW COVID-19 antigen over-the-counter test kits (12 tests per box, 2 boxes per case). The contract is structured as a fixed-price agreement with economic price adjustment provisions and is set to be completed by June 9, 2025, with performance taking place in Pittsburgh, Pennsylvania. This award represents a child contract under a larger procurement vehicle and was issued through open competition with no set-aside designation, reflecting Fisher Scientific's established capability to compete effectively in federal medical supply procurement. As a major supplier of laboratory, scientific, and medical products to federal agencies, Fisher Scientific brings substantial experience in delivering specialized testing solutions and medical equipment across multiple government departments. The company, registered in the System for Award Management since 2001, maintains significant relationships with defense-related agencies and has demonstrated expertise in procurement of diagnostic and testing supplies. This particular delivery order supports the federal government's ongoing access to rapid COVID-19 diagnostic testing capabilities, with the compressed completion timeline indicating urgent or immediate supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 6/2/25 |